Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Security of Annual and Biennial Zoledronic Acid for Osteoporosis Treatment in an HIV-infected Patients' Cohort

NCT00795483 is registered in ClinicalTrials.gov with Germans Trias i Pujol Hospital as lead sponsor.

NCT NCT00795483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Security of Annual and Biennial Zoledronic Acid for Osteoporosis Treatment in an HIV-infected Patients' Cohort
Lead sponsor
Germans Trias i Pujol Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
November 30, 2011
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections